Tina Van Buyten

Rega Institute for Medical Research — Belgium

Medicine · Health Sciences

12h-index1.6kcitations16works15.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(10), Long-Term Effects of COVID-19(10), SARS-CoV-2 and COVID-19 Research(6), Gut microbiota and health(2), Inflammasome and immune disorders(2)

Publications16 total

A coronavirus assembly inhibitor that targets the viral membrane protein
Nature·2025· 18 citedOpen Access
Mechanism of action of phthalazinone derivatives against rabies virus
Antiviral Research·2024· 3 citedOpen Access
Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
The Lancet Microbe·2024· 25 citedOpen Access
SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19
Frontiers in Cardiovascular Medicine·2022· 8 citedOpen Access
The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution
Cardiovascular Research·2022· 59 citedOpen Access
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
Nature Communications·2021· 91 citedOpen Access
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
Nature Communications·2021· 255 citedOpen Access
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages
Cell Research·2021· 374 citedOpen Access
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
2020· 15 citedOpen Access
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Nature Communications·2020· 287 citedOpen Access
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
Research Square (Research Square)·2020· 1 citedOpen Access
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
Proceedings of the National Academy of Sciences·2020· 281 citedOpen Access
Discriminating Mild from Critical COVID-19 by Innate and Adaptive Immune Single-cell Profiling of Bronchoalveolar Lavages
2020· 69 citedOpen Access
Antiviral treatment of SARS-CoV-2-infected hamsters reveals a weak effect of favipiravir and a complete lack of effect for hydroxychloroquine
2020· 31 citedOpen Access
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
2020· 55 citedOpen Access
Monocyte-Driven Atypical Cytokine Storm and Aberrant Neutrophil Activation as Key Mediators of COVID19 Disease Severity
SSRN Electronic Journal·2020· 11 citedOpen Access

Frequent Co-authors

Johan Neyts(16), Sander Jansen(11), Birgit Weynand(10), Els Wauters(9), Pierre Van Mol(9), Joost Wauters(9), Diether Lambrechts(9), Lore Vanderbeke(8), Jan Gunst(8), Greet Hermans(8), Philippe Meersseman(8), Bram Boeckx(7), Christophe Dooms(7), Yannick Van Herck(6), Elisabeth Heylen(6), Dries Testelmans(6), Jonas Yserbyt(6), Kimberly Martinod(6), Jeroen Raes(6), Karin Thevissen(6)